Phase II study of gemcitabine in children with relapsed leukemia

Pediatr Blood Cancer. 2006 Feb;46(2):262. doi: 10.1002/pbc.20632.
No abstract available

Publication types

  • Clinical Trial, Phase I
  • Comment
  • Letter
  • Multicenter Study

MeSH terms

  • Adolescent
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Antimetabolites, Antineoplastic / adverse effects
  • Child
  • Child, Preschool
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / adverse effects
  • Deoxycytidine / analogs & derivatives*
  • Female
  • Gemcitabine
  • Humans
  • Leukemia, Myeloid, Acute / complications
  • Leukemia, Myeloid, Acute / mortality
  • Leukemia, Myeloid, Acute / prevention & control*
  • Male
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / mortality
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / prevention & control*
  • Recurrence

Substances

  • Antimetabolites, Antineoplastic
  • Deoxycytidine
  • Gemcitabine